HIV Neurological Disorders
A special issue of Viruses (ISSN 1999-4915). This special issue belongs to the section "Human Virology and Viral Diseases".
Deadline for manuscript submissions: closed (30 November 2023) | Viewed by 15787
Special Issue Editor
Interests: neuroscience; neuropathology; cell biology; HIV
Special Issue Information
Dear Colleagues,
The challenge of HIV neurological disorders spans numerous neuroscience disciplines. Neurology, neuropathology, neurovirology, immunology, pharmacology, psychiatry, and psychology all contribute to improving the longevity and quality of life. However, because many antivirals cannot enter the brain due to the blood-brain barrier, HIV-associated neurological and cognitive symptoms can still persist. This creates two problems: it establishes the brain as a reservoir of viral infection and also makes the brain susceptible to the effects of HIV infection. The greater the time post-infection, the higher the probability that neurologic symptoms could emerge. Quality of life observably decreases and healthcare problems increase as neurocognitive and neurologic problems intensify. Therefore, there is a pressing need to understand the mechanism(s) by which HIV can affect the nervous system as this may facilitate new treatments.
This Special Issue seeks articles and reviews that focus on the neuroscience of HIV/AIDS infections. In addition, the Society for Neurosciences will be meeting in San Diego, 12–16 November 2022. Please visit the meeting link for more information (https://www.sfn.org/meetings/neuroscience-2022). There is often a section on HIV-related neuroscience abstracts. If you present on an HIV–neurological disorder, perhaps you can consider submitting a full-length paper to this Special Edition. We will also consider including a relevant overview of the presented neuroscience HIV-related abstracts.
Dr. Frank Denaro
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Viruses is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- HIV neuropathology
- HIV reservoir
- HIV proteins
- HIV receptors
- HIV models
- AIDS dementia complex
- neuroinflammation
- HIV noninfectious comorbidities
- HIV healthcare disparities
- treatment